Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation

By Zhang J.   Wang Q.   Zhao D.   Cao X.  

Cytotherapy, Vol. 9, Iss. 4, 2007-01 ,pp. : 386-396

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

By Li Hui   Wang Changli   Yu Jinpu   Cao Shui   Wei Feng   Zhang Weihong   Han Ying   Ren Xiu-bao  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 1076-1083

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma

By Guardino Ae   Rajapaksa R   Ong Kh   Sheehan K   Levy R  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 277-289

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Potent in vivo anti-tumor activity of isolated CD62L low lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines

By Liu Z   Fan H   Wu Y   Chen B  

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 353-362

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

By Trepiakas Redas   Berntsen Annika   Hadrup Sine Reker   Bjørn Jon   Geertsen Poul F.   Straten Per Thor   Andersen Mads H.   Pedersen Anders E.   Soleimani Amir   Lorentzen Torben   Johansen Julia S.   Svane Inge Marie  

Cytotherapy, Vol. 12, Iss. 6, 2010-10 ,pp. : 721-734

Ashgate Publishing Ltd

Access to resources Recommend Favorite